Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 3,601-3,612 of 10,592
Other study type icon
CompletedNCT02566980

Biological Triggers of Depression in Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

In United States
DepressionOtherOver 18 Years
Countries
United States
Sponsor
Michigan State University
Condition
Depression
Drug study icon
CompletedNCT02805972

Biology and Experience of Eating in Women With Obesity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Eating disordersDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Eating disorders
Drug study icon
CompletedNCT02404155

Biomarker and Safety Study of Clozapine in people with Benign Ethnic Neutropenia (BEN)

This study exists to see whether the medication Clozapine is workable and worth testing more broadly. Researchers are trying to understand how people respond to the medication Clozapine in practice and what may need to be adjusted.

In United States
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT01555697

Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Drug study icon
CompletedNCT00688324

Biomarker Study of Acamprosate in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Biological study icon
CompletedNCT02033382

Biomarkers in First Episode Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaOtherFrom 16 Years to 40 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
Drug study icon
CompletedNCT00817336

Biomarkers in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
CompletedNCT05650775

Biomarkers of ADHD Treatment Response

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
ADHDDrugFrom 7 Years to 11 Years
Countries
United States
Sponsor
Boston Children's Hospital
Condition
ADHD
Drug study icon
CompletedNCT03323437

Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

Remote / online
SchizophreniaDrugFrom 18 Years to 35 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.